The researchers’ goal was to study the frequency of electronic media usage by preschool children and the risks of high-dose e-media use on young children’s psychosocial well-being.
Parents report that the COVID-19 pandemic has negatively impacted the mental health of their teens.
Both formulations are indicated for patients aged 3 years and older; however, the tablet formulation is specifically approved for patients weighing 35kg or more.
More than 20 percent of children have incidental findings on brain magnetic resonance imaging conducted at age 9 to 10 years.
Pfizer Inc. announced Wednesday that its COVID-19 vaccine is safe and remarkably effective in children as young as 12 years.
Hypertensive disorders of pregnancy are associated with modestly increased risks for ASDs and possibly ADHD in offspring.
A team of researchers assessed the Novartis-Oxford Multiple Sclerosis data set to investigate the relationship between age, relapse frequency, and phenotypic presentation of multiple sclerosis.
The phase 3 SPR1NT trial is an ongoing open-label, single-arm study evaluating onasemnogene in presymptomatic patients (≤6 weeks of age) with a genetic diagnosis of SMA and 2 or 3 copies of survival motor neuron 2 gene.
A baseline MRI assessment and subsequent clinical and MRI monitoring during the first 2 years of pediatric multiple sclerosis onset can likely provide insights into 9-year prognosis.
The phase 2/3 KidCOVE study [ClinicalTrials.gov: NCT04796896] is evaluating the safety and effectiveness of the vaccine in healthy children between 6 months and less than 12 years of age.
